Skip to main content

Kronos Bio, Inc.

KRONDelisted Jun 20, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001741830

Kronos Bio, Inc. was delisted on Jun 20, 2025; its insiders filed their last Form 4 on Jun 20, 2025; 47 institutions reported holding it in 13F filings for Q1 2025, worth $15.8M in total; no superinvestor held it.

13F holders, Q3 2022

Institutional positions in Kronos Bio, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
96
+2 vs. Q2 2022
Shares held
36.1M
−834.6K (−2.3%) vs. Q2 2022
Total value
$120.8M
−$13.6M (−10.1%) vs. Q2 2022
New holders
12
26 more added
Sold out
10
32 more reduced

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting KRON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 96 institutions
Q1 2021: 71 institutionsQ2 2021: 77 institutionsQ3 2021: 83 institutionsQ4 2021: 81 institutionsQ1 2022: 96 institutionsQ2 2022: 94 institutionsQ3 2022: 96 institutionsQ4 2022: 97 institutionsQ1 2023: 87 institutionsQ2 2023: 80 institutionsQ3 2023: 63 institutionsQ4 2023: 60 institutionsQ1 2024: 58 institutionsQ2 2024: 56 institutionsQ3 2024: 53 institutionsQ4 2024: 56 institutionsQ1 2025: 47 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2022: $120.8M
Q1 2021: $1.05BQ2 2021: $956.8MQ3 2021: $811.6MQ4 2021: $557.8MQ1 2022: $282.0MQ2 2022: $134.4MQ3 2022: $120.8MQ4 2022: $55.9MQ1 2023: $47.3MQ2 2023: $54.3MQ3 2023: $39.3MQ4 2023: $33.4MQ1 2024: $28.2MQ2 2024: $25.6MQ3 2024: $19.7MQ4 2024: $18.7MQ1 2025: $15.8MQ2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding KRON and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 202547$15.8M
Q4 202456$18.7M
Q3 202453$19.7M
Q2 202456$25.6M
Q1 202458$28.2M
Q4 202360$33.4M
Q3 202363$39.3M
Q2 202380$54.3M
Q1 202387$47.3M
Q4 202297$55.9M
Q3 202296$120.8M
Q2 202294$134.4M
Q1 202296$282.0M
Q4 202181$557.8M
Q3 202183$811.6M
Q2 202177$956.8M
Q1 202171$1.05B

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Kronos Bio, Inc.; share changes are against Q2 2022.

Institutions holding KRON in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Man Group plc0$00.00%–Sold out
Delphia (USA) Inc.0$00.00%−14,256−100.0%Sold out
Corton Capital Inc.0$00.00%−13,103−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−11,200−100.0%Sold out
PDT Partners, LLC0$00.00%−10,041−100.0%Sold out
Meeder Asset Management Inc0$00.00%−3−100.0%Sold out